About BioChain
BioChain is a company based in Hayward (United States) founded in 1994. BioChain has raised $7.34 million across 2 funding rounds from investors including HHS and Ascendent Capital Partners. BioChain offers products and services including Biospecimens, Extraction Kits, Automated Instruments, and Custom Services. BioChain operates in a competitive market with competitors including Abcam, Sino Biological, GenScript, Stem Cell Technologies and Miltenyi Biotec, among others.
- Headquarter Hayward, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Biochain Institute, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$7.34 M (USD)
in 2 rounds
-
Latest Funding Round
$7.34 M (USD), Private Equity Round
Nov 11, 2016
-
Investors
HHS
& 1 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of BioChain
BioChain offers a comprehensive portfolio of products and services, including Biospecimens, Extraction Kits, Automated Instruments, and Custom Services.
High-quality tissues and samples for research and testing purposes
Kits for DNA, RNA, and protein extraction in laboratories
Devices for automated sample preparation and analysis
Tailored biospecimen procurement and analysis for clients
People of BioChain
Unlock access to complete
Unlock access to complete
Funding Insights of BioChain
BioChain has successfully raised a total of $7.34M across 2 strategic funding rounds. The most recent funding activity was a Private Equity Round of $7.34 million completed in November 2016. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Private Equity Round — $7.3M
-
First Round
First Round
(05 May 2008)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov, 2016 | Amount | Private Equity Round - BioChain | Valuation | Ascendent Capital Partners |
|
| May, 2008 | Amount | Grant - BioChain | Valuation |
investors |
Investors in BioChain
BioChain has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include HHS and Ascendent Capital Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location | |
|
Public health and human services are overseen by HHS.
|
Founded Year | Domain | Location |
Investments & Acquisitions by BioChain
Financial Statements - BioChain
Biochain Comparisons
Competitors of BioChain
BioChain operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Abcam, Sino Biological, GenScript, Stem Cell Technologies and Miltenyi Biotec, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Biological reagents and antibodies are developed for life science research.
|
|
| domain | founded_year | HQ Location |
Reagents and kits are provided for clinical research applications.
|
|
| domain | founded_year | HQ Location |
Reagents and instruments are provided for life sciences research.
|
|
| domain | founded_year | HQ Location |
Developer of cell culture media and ancillary reagents for life science research
|
|
| domain | founded_year | HQ Location |
Develops tools and products for research and clinical application
|
|
| domain | founded_year | HQ Location |
Provider of molecular diagnostic kits for cancer, hereditary diseases, and reproductive disorders
|
Latest news on Biochain
Frequently Asked Questions about BioChain
BioChain was founded in 1994 and raised its 1st funding round 14 years after it was founded.
BioChain is headquartered in Hayward, United States. It is registered at Hayward, California, United States.
Grace Tian is the current CEO of BioChain.
BioChain is a funded company, having raised a total of $7.34M across 2 funding rounds to date. The company's 1st funding round was a Grant of $200.44K, raised on May 05, 2008.
Provider of products and services for clinical diagnosis, genomics, and proteomics. The products (markers, kits, reagents) for DNARNA and proteins related research. It provides kits for sequencing, enzyme assays, PCR, immunodiagnostics. Also offers an extensive collection of tissue blocks, slides, frozen arrays, and FFPE arrays for human normal, diseased, and tumor tissue types. It provides custom services such as clinical samples collection, extraction and purification, tissue section and array, and others.
BioChain's top competitors include Abcam, Sino Biological and Meridian Bioscience.
BioChain offers Biospecimens, Extraction Kits, Automated Instruments, and Custom Services.
BioChain has 2 investors. Key investors include HHS, and Ascendent Capital Partners.